Business / Finance

RSS

Cryoport net revenues increase 44% to $1.2 million in fourth quarter 2015

Cryoport, Inc. today announced financial results for the three and twelve-month periods ended March 31, 2015.

19 May 2015

BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, announces that it has signed an agreement with Genmab A/S to jointly research, develop and commercialize multiple bispecific antibodies for cancer immunotherapy using proprietary technologies from both companies: BioNTech's proprietary immunomodulatory antibodies and Genmab's DuoBody technology platform.

19 May 2015

Linkam and Cambridge IVF work on the development of new protocols for sperm testing

IVF is becoming increasingly important as fertility and birth rates fall in developed countries. Ensuring patients get the right treatment is important both from an emotional and financial perspective...

From Linkam Scientific Instruments 18 May 2015

Healthy Delights launches five new products in GNC stores nationwide

Healthy Delights®, the leaders in confectionary nutritional products, is proud to launch five new products in GNC stores nationwide: Probiotic Chocolate Bites, Probiotic Greek Yogurt Bites, Turmeric Curcumin Chews, Magnesium Chews, and Cranberry Chews.

18 May 2015

Lab M demonstrates quality with compliance to ISO 11133:2014

Lab M has been compliant according to ISO 11133:2014 which relates to the microbiology of food, animal feed and water – culture media preparation, production, storage and testing...

18 May 2015

Immune Pharmaceuticals announces Q1 2015 financial results; files Quarterly Report on Form 10-Q

Immune Pharmaceuticals Inc. announced financial results for the first quarter ended March 31, 2015. Immune filed its Quarterly Report on Form 10-Q for the first quarter of 2015 on Friday, May 15, 2015.

18 May 2015

Catasys' total revenues increase 118% to $433,000 in first quarter 2015

Catasys, Inc., provider of proprietary health management services to health insurers and employers, today reported its first quarter 2015 financial results for the period ended March 31, 2015.

18 May 2015

AbbVie extends expiration of exchange offer to acquire common stock of Pharmacyclics

AbbVie Inc. today announced that it has extended the expiration of its exchange offer to acquire all of the outstanding shares of common stock of Pharmacyclics, Inc. to 5 p.m., New York City time, on May 22, 2015.

18 May 2015

Olympus becomes exclusive distributor of Terumo's GLIDEWIRE Urologic Guidewire in the U.S.

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today that it has partnered with Terumo Corporation to be the exclusive distributor of the GLIDEWIRE Urologic Hydrophilic Coated Guidewire, a device cleared by the FDA for urological use.

17 May 2015

CASI Pharmaceuticals reports net loss of $1.8 million for first quarter 2015

CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China today reported financial results for the three months ended March 31, 2015.

15 May 2015

Complete skin grafting solution to launch at Hospitalar 2015

A complete skin grafting solution for burns and trauma surgery enabling flexibility of thin and thick skin grafts will be launched by Surtex Instruments at Hospitalar 2015.

14 May 2015

EKF highlighting its expanding range of liquid stable clinical chemistry reagents at Hospitalar 2015

EKF Diagnostics will be highlighting its expanding Stanbio central laboratory clinical chemistry range at Hospitalar, 19–22 May, Sao Paulo, Brazil.

From EKF Diagnostics 14 May 2015

Great Basin Scientific revenue up 31% in first quarter 2015

Great Basin Scientific, Inc., a molecular diagnostic testing company, today reported earnings results for the quarter ended March 31, 2015. Revenue for the quarter was $458,730, which represented a 31 percent increase in year-over-year revenues, and Loss from Operations was $3.9 million.

14 May 2015

Denali launched to discover, develop effective medicines for neurodegenerative diseases

Denali Therapeutics Inc., a new biotechnology company focused on developing effective therapies for neurodegenerative diseases, announced today that it has launched with an initial investment commitment of $217 million.

14 May 2015

ZenBio, Inc. introduces GroPro™ Cell Culture Growth Supplement formulated  to replace Bovine serum

ZenBio, Inc. industry leader in robust cell-based solutions, announced today the worldwide release of a new GroPro Cell Culture Growth Supplement...

14 May 2015

BrainStorm Cell Therapeutics reports financial results for Q1 2015, provides business update

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced financial results and provided a business update for the first quarter ended March 31, 2015.

14 May 2015

LABINDIA to promote Dotmatics’ scientific informatics solutions, services in India

Dotmatics, the leading provider of scientific informatics solutions and services for the pharma, biotech, chemicals, agrochemicals and academia announced today that it has appointed LABINDIA as a distributor in India.

14 May 2015

Save the date: MEDICA and COMPAMED from 16 – 19 November 2015

Planning is already running at full blast for the MEDICA 2015 and COMPAMED 2015 being held in parallel...

13 May 2015

Galmed reports net loss of $2.5 million for first quarter 2015

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases, today announced financial results for the three months ended March 31, 2015.

13 May 2015

Soligenix, Emergent BioSolutions sign development agreement

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has initiated a development agreement with Emergent BioSolutions to implement a commercially viable, scalable production technology for the RiVax drug substance protein antigen.

13 May 2015

Business / Finance

Cryoport net revenues increase 44% to $1.2 million in fourth quarter 2015

BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

Linkam and Cambridge IVF work on the development of new protocols for sperm testing

Healthy Delights launches five new products in GNC stores nationwide

Lab M demonstrates quality with compliance to ISO 11133:2014

Immune Pharmaceuticals announces Q1 2015 financial results; files Quarterly Report on Form 10-Q

Catasys' total revenues increase 118% to $433,000 in first quarter 2015

AbbVie extends expiration of exchange offer to acquire common stock of Pharmacyclics

Olympus becomes exclusive distributor of Terumo's GLIDEWIRE Urologic Guidewire in the U.S.

CASI Pharmaceuticals reports net loss of $1.8 million for first quarter 2015

Complete skin grafting solution to launch at Hospitalar 2015

EKF highlighting its expanding range of liquid stable clinical chemistry reagents at Hospitalar 2015

Great Basin Scientific revenue up 31% in first quarter 2015

Denali launched to discover, develop effective medicines for neurodegenerative diseases

ZenBio, Inc. introduces GroPro™ Cell Culture Growth Supplement formulated  to replace Bovine serum

BrainStorm Cell Therapeutics reports financial results for Q1 2015, provides business update

LABINDIA to promote Dotmatics’ scientific informatics solutions, services in India

Save the date: MEDICA and COMPAMED from 16 – 19 November 2015

Galmed reports net loss of $2.5 million for first quarter 2015

Soligenix, Emergent BioSolutions sign development agreement

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News